Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $35 | In Stock | |
10 mg | $60 | In Stock | |
25 mg | $123 | In Stock | |
50 mg | $197 | In Stock | |
100 mg | $289 | In Stock | |
500 mg | $698 | In Stock |
Description | Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. |
Targets&IC50 | TTR:2.7-3.2 μM (EC50) |
In vitro | Tafamidis selectively binds with negative cooperativity (K(d)s ~2 nM and ~200 nM) to the two thyroxine-binding sites of the TTR tetramer, kinetically stabilizing TTR. It also stabilizes patient-derived amyloidogenic TTR variants, including kinetically and thermodynamically less stable mutants[1]. |
Alias | Fx-1006A |
Molecular Weight | 503.33 |
Formula | C21H24Cl2N2O8 |
Cas No. | 951395-08-7 |
Smiles | CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5.03 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.